Access to anti-retroviral drugs, male in Egypt
Egypt: Access to anti-retroviral drugs, male was 44.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Egypt, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Egypt recorded 44.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.
That represents a change of up 18.9% on the previous year and up 633.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Egypt peaked at 44.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Egypt 126th out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Egypt, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 1.0% | +0.0% |
| 2008 | 2.0% | +100.0% |
| 2009 | 2.0% | +0.0% |
| 2010 | 3.0% | +50.0% |
| 2011 | 3.0% | +0.0% |
| 2012 | 4.0% | +33.3% |
| 2013 | 5.0% | +25.0% |
| 2014 | 6.0% | +20.0% |
| 2015 | 7.0% | +16.7% |
| 2016 | 10.0% | +42.9% |
| 2017 | 13.0% | +30.0% |
| 2018 | 18.0% | +38.5% |
| 2019 | 21.0% | +16.7% |
| 2020 | 25.0% | +19.0% |
| 2021 | 28.0% | +12.0% |
| 2022 | 34.0% | +21.4% |
| 2023 | 37.0% | +8.8% |
| 2024 | 44.0% | +18.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.6% | 0.0% | 2.0% | 10 |
| 2010s | 9.0% | 3.0% | 21.0% | 10 |
| 2020s | 33.6% | 25.0% | 44.0% | 5 |
Countries ranked near Egypt
- 125 Bangladesh 45.0% compare
- 126 Indonesia 44.0% compare
- 128 Mongolia 42.0% compare
- 128 Philippines 42.0% compare
More gender data for Egypt
- Child population (UN estimates and projections) 36,649 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.6533 % change on previous year (2030)
- Population 90,490 (2030)
- Working-age population (UN estimates and projections) 90,490 (2030)
- Population (UN estimates and projections), annual growth rate 2.27 % change on previous year (2030)
- Age population, age 00, female, interpolated 1.18 million (2025)
- Age population, age 00, male, interpolated 1.24 million (2025)
- Age population, age 01, female, interpolated 1.17 million (2025)
- Age population, age 01, male, interpolated 1.23 million (2025)
- Age population, age 02, female, interpolated 1.15 million (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Egypt?
- Access to anti-retroviral drugs, male in Egypt was 44.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Egypt?
- The highest recorded value was 44.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Egypt?
- The lowest recorded value was 0.0% in 2000.
- How does Egypt rank for access to anti-retroviral drugs, male?
- Egypt ranks 126th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Egypt?
- Over the last ten years it is up 633.3%. The long-run trend across the full record is volatile.
- Where does this Egypt data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.